A Harvard astrophysicist suggests a mysterious solar system object, 3I/ATLAS, might be a nuclear-powered spacecraft, challenging NASA's assessment. As it approaches Earth, the debate intensifies.
A groundbreaking Harvard study suggests lithium may reverse Alzheimer's-like changes in mice, igniting hope among advocates for earlier detection and new treatments. Experts urge caution and further research.
Tom Lehrer, the beloved humorist and pianist known for his satirical songs, has died at the age of 97. His unique blend of humor and music captivated audiences for decades. Lehrer’s legacy will live on through his witty compositions and impactful activism.
In a high-stakes court battle, Harvard and the Trump administration clash over the potential loss of $2.6 billion in federal funding. With accusations of antisemitism and control over the Ivy League's operations, the legal drama unfolds.
A groundbreaking study suggests that the sex of a baby may not be random but influenced by family-specific factors like maternal age and genetics, challenging long-held beliefs.
As Trump navigates his first 100 days, he faces declining approval ratings, a tariff agreement with China, and a contentious battle with Harvard over funding. Discover the key highlights and challenges of his presidency so far.
The Trump administration resumes student visa appointments but enforces strict social media vetting to screen for potential hostility towards the U.S. This move raises concerns about free speech and its implications for foreign students.
In a bold move, a Turkish private equity firm has injected $39 million into a Harvard lab, aiming to pioneer new therapies for metabolic conditions. This unique financing approach could reshape academic funding in the future.
Discover how Fortune Media is shaping the future with its insights into market trends and business opportunities for 2025. Don't miss out on what’s next!
In his first 100 days, Trump faces mounting opposition as tariffs on China are eased despite ongoing legal battles. Discover the latest on the Harvard funding feud and more.
